[1]ZHANG Y,ZHOU WG,ZHAO LB.The prognostic superiority of log odds of positive lymph nodes in patients with stage Ⅲ rectal cancer[J].Chinese Journal of Laboratory Diagnosis,2018,22(10):1687-1691.[张颖,周维国,赵丽波.阳性淋巴结对数比分期对Ⅲ期直肠癌患者预后的评估价值[J].中国实验诊断学,2018,22(10):1687-1691.]
[2]ZHEN W,ZHANG L,WU YL,et al.The association of metastasis-related indexes of lymph nodes and the prognosis of stage N2b colorectal cancer patients[J].Chin J Oncol,2018,40(9):679-683.[郑玮,张林,武云龙,等.N2b期结直肠癌淋巴结转移指标与患者预后的关系[J].中华肿瘤杂志,2018,40(9):679-683.]
[3]DING LJ,ZHAO LZ,WANG Y,et al.Studying the health risk assessment model of Chinese colorectal cancer[J].Chinese Journal of Prevention and Control of Chronic Diseases,2018,26(5):325-328.[丁兰君,赵丽中,王媛,等.中国结直肠癌健康风险评估模型研究[J].中国慢性病预防与控制,2018,26(5):325-328.]
[4]Ulanja MB,Beutler BD,Rishi M,et al.Colorectal cancer presentation and survival in young individuals:A retrospective cohort study[J].Cancers (Basel),2018,10(12).pii:E472.
[5]XIONG QM,YAN WY,HU J,et al.Clinicopathological characteristic and prognosis analysis of young patients with colorectal cancer[J].Modern Oncology,2018,26(6):888-892.[熊启敏,严文跃,胡静,等.原发性年轻结直肠癌患者的病理特征及预后分析[J].现代肿瘤医学,2018,26(6):888-892.]
[6]LU JY,XU L,ZHANG GN,et al.Oncological outcomes analysis of colorectal cancer with unfavorable histological features[J].Chin J Surg,2018,56(11):843-848.[陆君阳,徐徕,张冠南,等.不良组织学特征对结直肠癌肿瘤学治疗效果的影响[J].中华外科杂志,2018,56(11):843-848.]
[7]YANG XF,DU BB,ZHANG WS,et al.The relationship of rectal carcinoma patient's intra-angiologia cancer-embolus with clinical pathological factors and prognosis[J].Chin J Coloproctol,2015,35(6):10-11.[杨熊飞,杜斌斌,张维胜,等.直肠癌患者脉管内癌栓与临床病理因素及预后的关系[J].中国肛肠病杂志,2015,35(6):10-11.]
[8]Memon MA,Yunus RM,Memon B,et al.A meta-analysis and systematic review of perioperative outcomes of laparoscopic-assisted rectal resection (LARR) versus open rectal resection (ORR) for carcinoma[J].Surg Laparosc Endosc Percutan Tech,2018,28(6):337-348.
[9]TANG Y,LU XM,TONG Q,et al.Laparoscopic versus open surgery in treating colorectal cancer:A comparative study on postoperative incidence of anastomotic leakage and clinical effectiveness[J].J Clin Surg,2018,26(1):39-42.[汤瑜,卢晓明,童强,等.腹腔镜与开腹手术在结直肠癌术后吻合口瘘发病率及临床疗效的对比研究[J].临床外科杂志,2018,26(1):39-42.]
[10]XU QW,XU FP,WANG FF,et al.Laparoscopic assisted colorectal cancer surgery and open colectomy for colon cancer[J].Chin J Oper Proc Gen Surg(Electronic Edition),2016,10(2):112-115.[许庆文,徐飞鹏,王妃凤,等.腹腔镜辅助与开腹结直肠癌根治术临床对比研究[J].中华普外科手术学杂志(电子版),2016,10(2):112-115.]
[11]QIAO FN,CAO ZJ,YANG XD.Expression levels and clinical value of serum carcinoembryonic antigen,carbohydrate antigen 19-9 in colorectal cancer[J].Modern Oncology,2015,23(9):1255-1258.[乔峰妮,曹暂剑,杨向东.结直肠癌血清癌胚抗原、糖类抗原19-9表达水平及其临床价值探讨[J].现代肿瘤医学,2015,23(9):1255-1258.]
[12]ZHANG XD,GE XL,LIU SC,et al.The prognostic and predictive value of serum CA199 and CEA in colorectal cancer metastasis[J].Chin J Dis Control Prev,2018,22(1):57-61.[张鑫东,葛晓蕾,刘省存,等.血清CA199和CEA对结直肠癌转移和预后预测的价值[J].中华疾病控制杂志,2018,22(1):57-61.]
[13]YAN B,YANG T,XUE TH,et al.Prognostic value of combined examination of pre-operative carcinoembryonic antigen and CD44v6 for judging colorectal cancer[J].Cancer Res Clinic,2018,30(11):744-748.[颜兵,杨涛,薛天慧,等.术前联合检测癌胚抗原和CD44v6对判断结直肠癌患者预后的价值[J].肿瘤研究与临床,2018,30(11):744-748.]
[14]ZHANG CD,HE J,HUANG T,et al.Clinical significance of CEA and D-dimer levels in patients with colorectal cancer[J].Chinese Journal of Cancer Prevention and Treatment,2018,25(4):282-286.[张成大,何君,黄婷,等.结直肠癌患者血清CEA和D-二聚体检测临床意义[J].中华肿瘤防治杂志,2018,25(4):282-286.]
[15]HUANG LJ,FANG JF,WU JK,et al.Prognostic value of combining preoperative serum tumor markers and peripheral blood routine indexes in patients with colorectal cancer[J].Chin J Gastrointest Surg,2018,21(12):1421-1426.[黄利军,方佳峰,吴珏堃,等.术前血清肿瘤标志物联合血常规指标对结直肠癌患者预后评估的价值[J].中华胃肠外科杂志,2018,21(12):1421-1426.]